Abstract
Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.
| Original language | English |
|---|---|
| Journal | International Journal of Radiation Oncology Biology Physics |
| Volume | 102 |
| Issue number | 3 |
| Pages (from-to) | 508-514 |
| Number of pages | 7 |
| ISSN | 0360-3016 |
| DOIs | |
| Publication status | Published - 1 Nov 2018 |
Fingerprint
Dive into the research topics of 'Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS